149 related articles for article (PubMed ID: 26327943)
21. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina.
Uzunovic-Kamberovic S
J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Bouchillon SK; Badal RE; Hoban DJ; Hawser SP
Clin Ther; 2013 Jun; 35(6):872-7. PubMed ID: 23623624
[TBL] [Abstract][Full Text] [Related]
23. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
Oktem IM; Gulay Z; Bicmen M; Gur D;
Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
[TBL] [Abstract][Full Text] [Related]
24. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
25. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of extended spectrum beta-lactamases among isolates of Enterobacteriaceae from urinary tract infections in southern Italy.
Caccamo M; Perilli M; Celenza G; Bonfiglio G; Tempera G; Amicosante G
Microb Drug Resist; 2006; 12(4):257-64. PubMed ID: 17227211
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli resistance to quinolones at a comprehensive cancer center.
Mihu CN; Rhomberg PR; Jones RN; Coyle E; Prince RA; Rolston KV
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):266-9. PubMed ID: 20471765
[TBL] [Abstract][Full Text] [Related]
29. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
30. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
Lindbäck H; Lindbäck J; Sylvan S; Melhus A
Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
Cui WL; Xu DX; Li WL; Wang LX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
[TBL] [Abstract][Full Text] [Related]
32. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Yang H; Chen H; Yang Q; Chen M; Wang H
Antimicrob Agents Chemother; 2008 Dec; 52(12):4268-73. PubMed ID: 18809939
[TBL] [Abstract][Full Text] [Related]
34. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
36. Etiologies of the urinary tract infections in a Yemeni City.
Nasher MA; Nasher TM; Gunaid AA
Saudi Med J; 2001 Jul; 22(7):599-602. PubMed ID: 11479641
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of quinolone-resistant urinary tract infections in Comanche County Memorial Hospital.
Siddiqui AA
J Okla State Med Assoc; 2008 Sep; 101(9):210-2. PubMed ID: 18856050
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
40. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.
Kronenberg A; Koenig S; Droz S; Mühlemann K
Clin Microbiol Infect; 2011 Dec; 17(12):1845-51. PubMed ID: 21880098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
